Climate change, sexual harassment, dangers for delivery workers and expungement of criminal records are among the workplace issues that trouble New Yorkers, according to a new report by Cornell labor and workplace experts.
The 2023 VCNG Continuation of Service Award was presented to Jennifer Ross, an Executive MBA Metro NY candidate in the Samuel Curtis Johnson Graduate School of Management at the Cornell SC Johnson College of Business.
In patients with severe artery blockage in the lower leg, an artery-supporting device called a resorbable scaffold is superior to angioplasty, according to the results of a large international clinical trial co-led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.
New York City Mayor Bill de Blasio recently announced guidance for restaurants planning to provide comfort heating for customers dining outdoors during the fall and winter months. Max Zhang an expert in sustainable energy systems says although electric heaters emit no pollutants onsite compared to natural gas and propane heaters, electric heating actually causes more pollution in terms of greenhouse gas emissions.
The Cornell University Hospital for Animals now has the capability of cleansing patients’ blood outside of their bodies, opening the door to new treatment options, including dialysis for animals with kidney failure.
The Fashion and Body Tech Lab is helping an entrepreneur invent a swim cap that aims to expand access to swimming for people of color and others with diverse hair types.
Noliwe Rooks, an expert in cultural and racial implications for education, says if New York City enacts the changes announced by Mayor de Blasio it would be a major step toward integrating the nation’s largest and most segregated school system.
Antibodies that summon white blood cells may play an important role in protecting infants from congenital infection with human cytomegalovirus, according to a study led by an investigator at Weill Cornell Medicine and NewYork-Presbyterian.
An artificial intelligence algorithm can determine non-invasively, with about 70% accuracy, if an in vitro fertilized embryo has a normal or abnormal number of chromosomes, according to a new study from researchers at Weill Cornell Medicine.
Researchers at Weill Cornell Medicine have uncovered a novel route to stimulate the growth of healthy insulin-producing pancreatic beta cells in a preclinical model of diabetes. The findings hold promise for future therapeutics that will improve the lives of individuals with Type 2 diabetes – a condition that affects more than 500 million people worldwide.
